Full text
PDFPage 831
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Freeman S. L., O'Brien P. C., Rizza R. A. Use of human ultralente as the basal insulin component in treatment of patients with IDDM. Diabetes Res Clin Pract. 1991 Jul;12(3):187–192. doi: 10.1016/0168-8227(91)90076-p. [DOI] [PubMed] [Google Scholar]
- Frier B. M., Sullivan F. M., Mair F. S., Koch I. M., Scotton J. B. Pharmacokinetics of human insulin zinc suspension (recombinant DNA) in normal man: a comparison with porcine insulin zinc suspension. Diabet Med. 1984 Sep;1(3):219–221. doi: 10.1111/j.1464-5491.1984.tb01956.x. [DOI] [PubMed] [Google Scholar]
- Griffith D. N., Yudkin J. S. Brittle diabetes in the elderly. Diabet Med. 1989 Jul;6(5):440–443. doi: 10.1111/j.1464-5491.1989.tb01201.x. [DOI] [PubMed] [Google Scholar]
- Hildebrandt P., Berger A., Vølund A., Kühl C. The subcutaneous absorption of human and bovine ultralente insulin formulations. Diabet Med. 1985 Sep;2(5):355–359. doi: 10.1111/j.1464-5491.1985.tb00650.x. [DOI] [PubMed] [Google Scholar]
- Holman R. R., Turner R. C. A practical guide to basal and prandial insulin therapy. Diabet Med. 1985 Jan;2(1):45–53. doi: 10.1111/j.1464-5491.1985.tb00592.x. [DOI] [PubMed] [Google Scholar]
- Tindall H., Bodansky H. J., Stickland M., Wales J. K. A strategy for selection of elderly type 2 diabetic patients for insulin therapy, and a comparison of two insulin preparations. Diabet Med. 1988 Sep;5(6):533–536. doi: 10.1111/j.1464-5491.1988.tb01046.x. [DOI] [PubMed] [Google Scholar]
- Williams G., Patrick A. W. Human insulin and hypoglycaemia: burning issue or hot air? BMJ. 1992 Aug 8;305(6849):355–357. doi: 10.1136/bmj.305.6849.355. [DOI] [PMC free article] [PubMed] [Google Scholar]